Spectral Medical Inc.
EDTXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,286 | $1,598 | $1,667 | $2,052 |
| % Growth | 43.1% | -4.1% | -18.8% | – |
| Cost of Goods Sold | $1,268 | $936 | $684 | $832 |
| Gross Profit | $1,018 | $662 | $983 | $1,220 |
| % Margin | 44.5% | 41.4% | 59% | 59.5% |
| R&D Expenses | $0 | $0 | $3,100 | $0 |
| G&A Expenses | $11,615 | $10,995 | $8,008 | $9,434 |
| SG&A Expenses | $11,615 | $10,995 | $8,008 | $9,434 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,400 | -$10,333 | -$2,190 | -$93 |
| Operating Expenses | $13,015 | $662 | $8,233 | $9,728 |
| Operating Income | -$11,997 | -$15,306 | -$9,440 | -$8,601 |
| % Margin | -524.8% | -957.8% | -566.3% | -419.2% |
| Other Income/Exp. Net | -$3,398 | -$201 | $819 | -$302 |
| Pre-Tax Income | -$15,395 | -$15,507 | -$9,593 | -$8,785 |
| Tax Expense | $0 | $0 | -$429 | -$65 |
| Net Income | -$15,402 | -$15,662 | -$11,250 | -$8,785 |
| % Margin | -673.8% | -980.1% | -674.9% | -428.1% |
| EPS | -0.055 | -0.056 | -0.042 | -0.035 |
| % Growth | 1.3% | -33.6% | -19.8% | – |
| EPS Diluted | -0.055 | -0.056 | -0.042 | -0.035 |
| Weighted Avg Shares Out | 280,049 | 281,352 | 269,843 | 252,464 |
| Weighted Avg Shares Out Dil | 280,049 | 278,563 | 269,843 | 252,464 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,177 | $1,334 | $176 | $28 |
| Depreciation & Amortization | $251 | $218 | $272 | $294 |
| EBITDA | -$11,967 | -$13,955 | -$7,702 | -$6,375 |
| % Margin | -523.5% | -873.3% | -462% | -310.7% |